← Back to Search

Behavioural Intervention

Vibrotactile Therapy for Parkinson's Disease

Q: Am I allowed to participate in this clinical investigation?

<p>Qualifying patients, who must have <a href="https://www.withpower.com/clinical-trials/parkinson">parkinson</a>'s and are between the ages of 18-92, can enroll in this clinical trial. The research team is actively seeking to recruit 34 individuals for participation.</p>

N/A

Waitlist Available

Led By Vivek P Buch, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 18 or older

Diagnosed with idiopathic Parkinson's Disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and month 6

Awards & highlights

Study Summary

This trial tests a non-invasive glove that may help improve Parkinson's symptoms. Patients will be monitored for 14 months to see the effects.

Who is the study for?

This trial is for adults over 18 with Parkinson's Disease who can understand and agree to the study rules. They must have a certain level of motor impairment and not be in other trials, pregnant, or have sensory issues in their fingers or implanted medical devices.Check my eligibility

What is being tested?

The study tests the Stanford Glove delivering Vibrotactile Coordinated Reset stimulation (vCR) as a non-invasive treatment option for Parkinson's symptoms. Participants will use this device and be monitored over a period of 14 months.See study design

What are the potential side effects?

Since vCR is non-invasive and doesn't involve drugs, side effects might include discomfort at the site of stimulation on the hand or skin irritation from wearing the glove.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with Parkinson's Disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and month 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and month 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in MDS-Unified Parkinson's Disease Rating Scale Part III Scale Score

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Active stimulationActive Control1 Intervention

Participants will receive active stimulation between 2 hours minimum and 4 hours maximum of daily vCR or sham stimulation (2 hours twice daily) at home for the first month (30 days), followed by a minimum of 1.5 hours and a maximum of 2.5 hours of daily vCR

Group II: Sham StimulationPlacebo Group1 Intervention

Participants will receive sham stimulation between 2 hours minimum and 4 hours maximum of daily vCR or sham stimulation (2 hours twice daily) at home for the first month (30 days), followed by a minimum of 1.5 hours and a maximum of 2.5 hours of daily vCR

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,387 Previous Clinical Trials

17,334,016 Total Patients Enrolled

Vivek P Buch, MDPrincipal InvestigatorStanford University

1 Previous Clinical Trials

100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I allowed to participate in this clinical investigation?

"Qualifying patients, who must have parkinson's and are between the ages of 18-92, can enroll in this clinical trial. The research team is actively seeking to recruit 34 individuals for participation."

Answered by AI

Are elderly patients being accepted for inclusion in this trial?

"To be considered for this clinical trial, applicants must fall within the 18 to 92 year old age range. Separately, there are 24 trials specifically designed for minors and 535 studies that cater to elderly populations."

Answered by AI

Are there any opportunities to enroll in this research project at the present moment?

"According to clinicaltrials.gov, this medical trial is no longer seeking patients. It was first announced on October 29th 2023 and last edited on August 31st 2023; however, there are currently 540 other trials that require enrollment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study

Vivek P. Buch 2023. "Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06028477.